Cheng-Lin Liu (Chenglin Liu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Ejection Fraction

Acute Lymphoblastic Leukemia

Top Venues

Nature communications

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shuang-Shuang Yang, Jie Xu, Yu-Ting Dai, Shiwei Jin, Yan Sun, Jian-Feng Li, Cheng-Lin Liu, Xiaolin Ma, Zhu Chen, Lijuan Chen, Jian Hou, Jian-Qing Mi, Sai-Juan Chen
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma. Nature communications 15 (1) (2024)
Shuang-Shuang Yang, Jie Xu, Yu-Ting Dai, Shiwei Jin, Yan Sun, Jian-Feng Li, Cheng-Lin Liu, Xiaolin Ma, Zhu Chen, Lijuan Chen, Jian Hou, Jian-Qing Mi, Sai-Juan Chen
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma. Nature communications 15 (1) (2024)
Shuang-Shuang Yang, Jie Xu, Yu-Ting Dai, Shiwei Jin, Yan Sun, Jian-Feng Li, Cheng-Lin Liu, Xiaolin Ma, Zhu Chen, Lijuan Chen, Jian Hou, Jian-Qing Mi, Sai-Juan Chen
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma. Nature communications 15 (1) (2024)
Shuang-Shuang Yang, Jie Xu, Yu-Ting Dai, Shiwei Jin, Yan Sun, Jian-Feng Li, Cheng-Lin Liu, Xiaolin Ma, Zhu Chen, Lijuan Chen, Jian Hou, Jian-Qing Mi, Sai-Juan Chen
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma. Nature communications 15 (1) (2024)
Yan Sun, Xiu-Na Yang, Shuang-Shuang Yang, Yi-Zhu Lyu, Bing Zhang, Kai-Wen Liu, Na Li, Jia-Chen Cui, Guang-Xiang Huang, Cheng-Lin Liu, Jie Xu, Jian-Qing Mi, Zhu Chen, Xiao-Hu Fan, Sai-Juan Chen, Shuo Chen
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity. Signal transduction and targeted therapy 8 (1) (2023)